Exposure to endocrine disrupting chemicals (EDCs) can lead to negative health outcomes in humans and wildlife as EDCs interfere with the endocrine system of hormones and glands. EDCs can be found in household products, consumer products, agriculture, aquaculture, industrial production, and transportation. Humans are exposed through food, consumer products, air, or water, amongst others. Similarly, EDCs are released into the environment through excretion, landfills, runoff from agriculture and urban areas, industry and leaching of wastes. They are not fully captured by wastewater treatment plants, leading to detected contamination of rivers, lakes, groundwater, estuaries, sediments, wastewater, and drinking water.
Human exposure to EDCs could lead to birth defects, can affect neurodevelopment conditions and reproductive health, and is also linked to obesity and metabolic diseases. In wildlife, EDCs affect physiology, behaviour or health, notably through alterations of the hormonal system, reproductive dysfunctions, and the feminisation of male fish. Aquatic organisms are continuously exposed to EDCs when living in a contaminated habitat. Contamination can cascade onto other organisms, populations and communities, through food chain for instance.
Parts of the costs of exposure to EDCs can be monetised. Estimated health care costs amount to CAD 24.6 billion in Canada; EUR 163 billion in the European Union; and USD 340 billion in the United States. The health-related costs from the exposure to per- and polyfluoroalkyl substances (PFAS), a group of persistent chemicals associated with environmental and human health concerns including endocrine disruption, have been estimated to range from EUR 2.8-4.6 billion, and the estimated environment-related costs ranged from EUR 46 million – EUR 11 billion over 20 years.